Department of Neurosurgery, China Medical University Hospital, Taichung 40402, Taiwan.
Evid Based Complement Alternat Med. 2012;2012:708452. doi: 10.1155/2012/708452. Epub 2012 Mar 12.
We tested the effect of Astragalus membranaceus (AM) on acute hemorrhagic stroke. Seventy-eight patients were randomly assigned to Group A (3 g of AM three times/day for 14 days); or Group B (3 g of placebo herb). A total of 68 patients (Group A 36, Group B 32) completed the trial. The increase of functional independence measure scale score between baseline and week 4 was 24.53 ± 23.40, and between baseline and week 12 was 34.69 ± 28.89, in the Group A was greater than 11.97 ± 11.48 and 23.94 ± 14.8 in the Group B (both P≦0.05). The increase of Glasgow outcome scale score between baseline and week 12 was 0.75 ± 0.77 in the Group A was greater than 0.41 ± 0.50 in the Group B (P < 0.05). The results are preliminary and need a larger study to assess the efficacy of AM after stroke.
我们测试了黄芪（AM）对急性出血性中风的影响。78 名患者被随机分为 A 组（每天服用 3 克 AM 三次，共 14 天）；或 B 组（安慰剂草药）。共有 68 名患者（A 组 36 名，B 组 32 名）完成了试验。A 组在基线和第 4 周之间的功能独立性测量量表评分增加了 24.53±23.40，在基线和第 12 周之间增加了 34.69±28.89，大于 B 组的 11.97±11.48 和 23.94±14.8（均 P≦0.05）。A 组在基线和第 12 周之间的格拉斯哥结局量表评分增加了 0.75±0.77，大于 B 组的 0.41±0.50（P<0.05）。结果初步表明，需要进一步研究评估中风后 AM 的疗效。
